Drug intelligence / Profile preview

naringin

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Naringin is a naturally occurring flavanone glycoside found predominantly in citrus fruits such as grapefruit and lime. It consists of the aglycone naringenin linked to the disaccharide neohesperidose at the 7-carbon position. Naringin is responsible for the characteristic bitter taste of grapefruit and is used commercially for its debittering properties in juice production. In humans and other mammals, it is metabolized by the enzyme naringinase into its aglycone form (naringenin), which has higher bioactivity. Pharmacologically, naringin exhibits antioxidant, anti-inflammatory, antiapoptotic activities and can inhibit certain membrane transporters such as OATP1A2. It also modulates various signaling pathways including JAK/STAT and MAPK/ERK[1][4][5]. Its low solubility and bioavailability limit clinical use; however it remains widely studied for potential therapeutic applications.

Other names
柚皮苷naringosideNARINGENIN-7-O-NEOHESPERIDOSIDENARINGENIN7-O-NEOHESPERIDOSIDENARINGENIN 7-O-NEOHESPERIDOSIDECabinda bark extractNARINGIN WITH HPLCCitrus grandis OsbeckNARINGENIN-7-RHAMNOGLUCOSIDENARINGENIN7-RHAMNOGLUCOSIDENARINGENIN 7-RHAMNOGLUCOSIDE7-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2(S)-(4-hydroxyphenyl)-4H-1-benzopyran-4-oneringin
02

Targets

OATP1A2 (Solute carrier organic anion transporter family member 1A2)SLCO2B1 (Organic anion transporting polypeptide 2B1)

Beyond the preview

Go deeper on naringin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naringin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call